The blood–brain barrier (BBB) prevents efficient drug delivery to the central nervous system.
As a result, brain diseases remain one of the greatest unmet medical needs. Understanding …

Abstract Three-dimensional (3D) bioprinting offers promising solutions to the complex
challenge of vascularization in biofabrication, thereby enhancing the prospects for clinical …

Abstract Background The gelatin-methacryloyl (GelMA) polymer suffers shape fidelity and
structural stability issues during 3D bioprinting for bone tissue engineering while …

Abstract Gelatin methacryloyl (GelMA)/alginate-based hydrogels have shown great promise
in bioprinting, but their printability is limited at room temperature. In this paper, we present …

Over recent decades, three-dimensional (3D) bioprinting has been studied, improved, and
extensively applied to various areas such as medicine, healthcare, food technology, etc …

Three-dimensional (3D) printing technology has emerged as a revolutionary manufacturing
strategy that could realize rapid prototyping and customization. It has revolutionized the …

Until recent, there are no ideal small diameter vascular grafts available on the market. Most
of the commercialized vascular grafts are used for medium to large-sized blood vessels. As …

Despite the efforts devoted to drug discovery and development, the number of new drug
approvals have been decreasing. Specifically, cardiovascular developments have been …

Three-dimensional (3D) printing plays an important role in cardiovascular disease through
the use of personalised models that replicate the normal anatomy and its pathology with …

The adaptation and progress of 3D printing technology toward 3D bioprinting (specifically
adapted to biomedical purposes) has opened the door to a world of new opportunities and …